124I-Evuzamitide PET/CT Imaging In Patients With Lumbar Spinal Stenosis and Carpal Tunnel Syndrome
Part of paid clinical trials in Knoxville, Tennessee.
- Sponsor
- University of Tennessee Graduate School of Medicine
- Study ID
- NCT06907849
- Phase
- PHASE2
- Status
- Enrolling By Invitation
Conditions
- Cardiac Amyloidosis
- Carpal Tunnel Syndrome (CTS)
- Lumbar Spinal Stenosis
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- 124I-evuzamitide — DRUG124I-evuzamitide is an iodine-124 (124I) labeled 45 L-amino acid peptide (also known as p5+14) suitable for single dose PET/CT imaging. The peptide binds many forms of amyloid through multivalent electrostatic interactions with the amyloid fibril and with the ubiquitous amyloid-associated hypersulfated heparan sulfate proteoglycans.
Study Details
This clinical trial will use the amyloid-binding radiotracer, 124I-evuzamitide, to potentially detect amyloid, in the heart and elsewhere, in patients who have a history of lumbar spinal stenosis and/or carpal tunnel syndrome.
Key Dates
- Start date
- May 31, 2025
- Status verified
- May 2025
- Primary completion
- Mar 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: BiodistributionParticipants will be administered \~1 mCi of 124I-evuzamitide (up to 1 mg of peptide) by IV push at a proposed rate of \~1 mL per 5 seconds. Three hours after injection, a PET/CT image acquisition from shoulder to thigh as well as a 10 min static PET image of the heart will be performed.
Primary Outcome Measure
Detection of cardiac amyloidosis using 124I-evuzamitide PET/CT imaging [ Time Frame: From enrollment to the end of study is 8 days. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Tennessee Graduate School of Medicine | Knoxville | Tennessee | 37920 | - |
Find similar trials in Knoxville, TN
Related Studies
- MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims StudyRecruiting · Stryker Instruments · Athens, Alabama
- Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.PHASE4 · Recruiting · Primus Pharmaceuticals · Auburn, Alabama
- Outcomes for Lumbar Decompressions With Use of Liposomal BupivicainePHASE2 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- Study Comparing Local/ MAC Anesthesia in Lumbar DecompressionEARLY_PHASE1 · Recruiting · Stanford University · Redwood City, California